Authors: Robichaud, A Tattersall, FD Choudhury, I Rodger, IW

Citation: A. Robichaud et al., Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret (vol 38, pg 289, 1999), NEUROPHARM, 40(3), 2001, pp. 465-465

Authors: Robichaud, A Savoie, C Stamatiou, PB Tattersall, FD Chan, CC

Citation: A. Robichaud et al., PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway, NEUROPHARM, 40(2), 2001, pp. 262-269

Authors: Harrison, T Owens, AP Williams, BJ Swain, CJ Williams, A Carlson, EJ Rycroft, W Tattersall, FD Cascieri, MA Chicchi, GG Sadowski, S Rupniak, NMJ Hargreaves, RJ

Citation: T. Harrison et al., An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration, J MED CHEM, 44(24), 2001, pp. 4296-4299

Authors: Tattersall, FD Rycroft, W Cumberbatch, M Mason, G Tye, S Williamson, DJ Hale, JJ Mills, SG Finke, PE MacCoss, M Sadowski, S Ber, E Cascieri, M Hill, RG MacIntyre, DE Hargreaves, RJ

Citation: Fd. Tattersall et al., The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L758,298, inhibit acute and delayed cisplatin-inducedemesis in ferrets, NEUROPHARM, 39(4), 2000, pp. 652-663

Authors: Hale, JJ Mills, SG MacCoss, M Dorn, CP Finke, PE Budhu, RJ Reamer, RA Huskey, SEW Luffer-Atlas, D Dean, BJ McGowan, EM Feeney, WP Chiu, SHL Cascieri, MA Chicchi, GG Kurtz, MM Sadowski, S Ber, E Tattersall, FD Rupniak, NMJ Williams, AR Rycroft, W Hargreaves, R Metzger, JM MacIntyre, DE

Citation: Jj. Hale et al., Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs, J MED CHEM, 43(6), 2000, pp. 1234-1241

Authors: Robichaud, A Tattersall, FD Choudhury, I Rodger, IW

Citation: A. Robichaud et al., Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret, NEUROPHARM, 38(2), 1999, pp. 289-297